Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

McKesson Corp (NY:MCK)

804.47 +11.50 (+1.45%)
Streaming Delayed Price Updated: 11:57 AM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about McKesson Corp

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
22 23 Next >
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,900 Today
 
Via Benzinga
McKesson (MCK) Q3 2024 Earnings Call Transcript
MCK earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
McKesson Corporation Reports Fiscal 2024 Third Quarter Results and Raises Full Year Guidance
From McKesson Corporation
Via Business Wire
McKesson Earnings Are Imminent; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
McKesson Corporation (NYSE: MCK) is expected to release earnings results for its third quarter, after the closing bell on Feb. 7, 2024. 
Via Benzinga
Earnings Scheduled For February 7, 2024
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million. 
Via Benzinga
Fear & Greed Index Remains In 'Greed' Zone Following Earnings Reports; Dow Jumps Over 100 Points
The CNN Money Fear and Greed index showed a slight improvement in the overall market sentiment, while the index remained in the "Greed" zone on Tuesday. U.S. stocks closed higher on Tuesday, as... 
Via Benzinga
Topics Stocks
Earnings Preview: McKesson
 
Via Benzinga
Here's How Much $1000 Invested In McKesson 5 Years Ago Would Be Worth Today
 
Via Benzinga
S&P 500 Flirts With 5,000 As Magnificent 7 Tops $13 Trillion, NYCB Sinks: What's Driving Markets Wednesday?
Wednesday is a bullish day on Wall Street, with major large-cap indices extending record highs, aided by robust corporate earnings. Despite the overall market optimism, concerns linger within segments... 
Via Benzinga
Topics Stocks
Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 3
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Jan. 29 through Feb. 2. 
Via Talk Markets
McKesson Corporation Declares Quarterly Dividend
From McKesson Corporation
Via Business Wire
Peering Into McKesson's Recent Short Interest
 
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $12,000 Today
 
Via Benzinga
Check Out What Whales Are Doing With MCK
 
Via Benzinga
McKesson Corp. (NYSE: MCK) Highlighted for Surprising Price Action
Via Investor Brand Network
Topics Economy
3 Hidden Healthcare Stocks Poised for a Breakout This Year
As the market preferences start to switch toward stable and defensive names like healthcare, these stocks could help your portfolio. 
Via InvestorPlace
McKesson Corp. (NYSE: MCK) Records 52-Week High Wednesday Morning
Via Investor Brand Network
Topics Economy
McKesson to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From McKesson Corporation
Via Business Wire
Exceeding Expectations: McKesson Achieves Strong Performance and Rewards Investors
On January 02, 2024, McKesson (NYSE:MCK) will distribute a dividend payout of $0.62 per share, equating to an annualized dividend yield of 0.55%. Shareholders who owned the stock before the ex-dividend... 
Via Benzinga
How Is The Market Feeling About McKesson?
 
Via Benzinga
Here's How Much You Would Have Made Owning McKesson Stock In The Last 5 Years
 
Via Benzinga
What 5 Analyst Ratings Have To Say About McKesson
 
Via Benzinga
McKesson Corporation Announces Third Quarter Fiscal 2024 Earnings Release Date and Participation in January Conference
From McKesson Corporation
Via Business Wire
Silver Economy Successes: 3 Stocks Benefitting From an Aging Population
Explore our in-depth analysis of aging population stocks, uncovering the opportunities and challenges in this sector. 
Via InvestorPlace
Topics Economy
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
The FDA approved Calliditas Therapeutics AB's (NASDAQ: CALT) Tarpeyo (budesonide) delayed-release capsules to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy... 
Via Benzinga
How Is The Market Feeling About McKesson?
 
Via Benzinga
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
New growth drivers are helping to propel these reliable and steady businesses. 
Via The Motley Fool
Here's How Much $100 Invested In McKesson 15 Years Ago Would Be Worth Today
 
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $13,000 Today
 
Via Benzinga
Teva Pharma is the way to play the re-rise of generic drugs
Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth 
Via MarketBeat
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.